Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors

NCT05693844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

BIOLOGICAL: Pan-T booster co-expressing MSLN CAR T cell
DRUG: Albumin-bound paclitaxel
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]